Literature DB >> 20956945

Upregulation of miR-21 by Ras in vivo and its role in tumor growth.

D Frezzetti1, M De Menna, P Zoppoli, C Guerra, A Ferraro, A M Bello, P De Luca, C Calabrese, A Fusco, M Ceccarelli, M Zollo, M Barbacid, R Di Lauro, G De Vita.   

Abstract

miR-21 is a microRNA (miRNA) frequently overexpressed in human cancers. Here we show that miR-21 is upregulated both in vitro and in vivo by oncogenic Ras, thus linking this miRNA to one of the most frequently activated oncogenes in human cancers. Ras regulation of miR-21 occurs with a delayed kinetic and requires at least two Ras downstream pathways. A screen of human thyroid cancers and non-small-cell lung cancers for the expression of miR-21 reveals that it is overexpressed mainly in anaplastic thyroid carcinomas, the most aggressive form of thyroid cancer, whereas in lung its overexpression appears to be inversely correlated with tumor progression. We also show that a LNA directed against miR-21 slows down tumor growth in mice. Consistently, a search for mRNAs downregulated by miR-21 shows an enrichment for mRNAs encoding cell cycle checkpoints regulators, suggesting an important role for miR-21 in oncogenic Ras-induced cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20956945     DOI: 10.1038/onc.2010.416

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  61 in total

Review 1.  The duality of oncomiR addiction in the maintenance and treatment of cancer.

Authors:  Christopher J Cheng; Frank J Slack
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

2.  NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression.

Authors:  Hirokazu Okayama; Motonobu Saito; Naohide Oue; Jonathan M Weiss; Jimmy Stauffer; Seiichi Takenoshita; Robert H Wiltrout; S Perwez Hussain; Curtis C Harris
Journal:  Int J Cancer       Date:  2012-06-13       Impact factor: 7.396

Review 3.  Deregulation of microRNA expression in thyroid neoplasias.

Authors:  Pierlorenzo Pallante; Sabrina Battista; Giovanna Maria Pierantoni; Alfredo Fusco
Journal:  Nat Rev Endocrinol       Date:  2013-11-19       Impact factor: 43.330

4.  MicroRNA-143 is a critical regulator of cell cycle activity in stem cells with co-overexpression of Akt and angiopoietin-1 via transcriptional regulation of Erk5/cyclin D1 signaling.

Authors:  Vien Khach Lai; Muhammad Ashraf; Shujia Jiang; Khawaja Haider
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

5.  MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome.

Authors:  Caterina Mian; Gianmaria Pennelli; Matteo Fassan; Mariangela Balistreri; Susi Barollo; Elisabetta Cavedon; Francesca Galuppini; Marco Pizzi; Federica Vianello; Maria Rosa Pelizzo; Maria Elisa Girelli; Massimo Rugge; Giuseppe Opocher
Journal:  Thyroid       Date:  2012-06-29       Impact factor: 6.568

6.  Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis.

Authors:  Xiaodong Ma; Munish Kumar; Saibyasachi N Choudhury; Lindsey E Becker Buscaglia; Juanita R Barker; Keerthy Kanakamedala; Mo-Fang Liu; Yong Li
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-06       Impact factor: 11.205

7.  miRNA-21 promotes cell proliferation and invasion via VHL/PI3K/AKT in papillary thyroid carcinoma.

Authors:  Chuanshan Zang; Jian Sun; Wenyi Liu; Chunqin Chu; Liwei Jiang; Ruifeng Ge
Journal:  Hum Cell       Date:  2019-06-03       Impact factor: 4.174

8.  The Potential Contribution of microRNAs in Anti-cancer Effects of Aurora Kinase Inhibitor (AZD1152-HQPA).

Authors:  Ali Zekri; Yashar Mesbahi; Elham Boustanipour; Zahra Sadr; Seyed H Ghaffari
Journal:  J Mol Neurosci       Date:  2018-07-26       Impact factor: 3.444

Review 9.  The microRNA networks of TGFβ signaling in cancer.

Authors:  V P Sivadas; S Kannan
Journal:  Tumour Biol       Date:  2013-12-10

10.  The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development.

Authors:  Zhengping Zhang; Yinhe Zha; Wei Hu; Zhen Huang; Zhongfei Gao; Yuhui Zang; Jiangning Chen; Lei Dong; Junfeng Zhang
Journal:  J Biol Chem       Date:  2013-11-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.